Please login to the form below

Not currently logged in
Email:
Password:

KantarHealth expands China team

KantarHealth continues to expand its leadership team in China, naming Hettie Han director of healthcare research in its Beijing office

KantarHealth continues to expand its leadership team in China, naming Hettie Han director of healthcare research in its Beijing office. Han will be responsible for providing research programmes and consulting guidance to help pharmaceutical and biotech clients optimise their business results in the Chinese market, anticipated to be the largest in the world by 2050.

Scott Davies, general manager of KantarHealth China said: "Hettie is a powerful addition to our senior team with more than a decade of pharmaceutical research experience, including deep expertise in the critical oncology category. Having spent her career working in pharmaceutical companies, she has firsthand insight into our customers' needs and challenges so can truly partner with them to drive their growth in the Chinese market."

Han commented: "I am excited by KantarHealth's commitment to supporting its clients' success – locally and around the world. Its focus on providing evidence-based decision support; its broad global footprint; its worldwide communities of business and therapeutics experts; and its unparalleled range of competencies, ensure I can always bring my customers the best solutions and best support team to maximise their performance."

Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, KantarHealth is the world's leading healthcare-focused global consultancy, speicliasing in portfolio optimisation, market access, safety and outcomes and brand and customer insights.

KantarHealth continues to expand its leadership team in China, naming Hettie Han director of healthcare research in its Beijing office. Han will be responsible for providing research programmes and consulting guidance to help pharmaceutical and biotech clients optimise their business results in the Chinese market, anticipated to be the largest in the world by 2050.

Scott Davies, general manager of KantarHealth China said: "Hettie is a powerful addition to our senior team with more than a decade of pharmaceutical research experience, including deep expertise in the critical oncology category. Having spent her career working in pharmaceutical companies, she has firsthand insight into our customers' needs and challenges so can truly partner with them to drive their growth in the Chinese market."

Han commented: "I am excited by KantarHealth's commitment to supporting its clients' success – locally and around the world. Its focus on providing evidence-based decision support; its broad global footprint; its worldwide communities of business and therapeutics experts; and its unparalleled range of competencies, ensure I can always bring my customers the best solutions and best support team to maximise their performance."

Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, KantarHealth is the world's leading healthcare-focused global consultancy, speicliasing in portfolio optimisation, market access, safety and outcomes and brand and customer insights.

30th September 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics